[CYCC] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
12-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- 45.23%
YoY- 48.87%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 0 0 0 0 139 512 396 -
PBT -1,510 -2,110 -1,531 -1,861 -3,534 -5,675 -5,446 -19.23%
Tax -290 -268 -182 -306 -493 -763 -569 -10.61%
NP -1,220 -1,842 -1,349 -1,555 -3,041 -4,912 -4,869 -20.58%
Tax Rate - - - - - - - -
Total Cost 1,220 1,842 1,349 1,555 3,180 5,424 5,265 -21.61%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 -2,187.77 -959.38 -1,229.55 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -1.42 -2.70 -2.25 -7.28 -20.51 -45.23 -59.83 -46.36%
EPS Diluted -1.42 -2.70 -2.25 -7.28 -20.51 -45.23 -59.83 -46.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.